Matt Kaeberlein

Doing cool things, with cool people, to raise all boats

Matt Kaeberlein is the Chief Executive Officer and Co-Founder of Optispan, a healthcare technology company focused on building tools for science-based preventative medicine and healthspan optimization.1 3 Here are some key details about Dr. Kaeberlein:

Professional Background

Affiliate Professor of Oral Health Sciences at the University of Washington2 3
Co-Director of the Dog Aging Project2 3
Former Professor of Laboratory Medicine and Pathology at the University of Washington (2015-2023)3
Former Director of the University of Washington Healthy Aging and Longevity Research Institute2
Former Director of the NIH Nathan Shock Center of Excellence in the Basic Biology of Aging2

Research Focus

Dr. Kaeberlein's research interests are centered on understanding biological mechanisms of aging to develop interventions that promote healthspan and improve quality of life for both humans and companion animals.2 He has published over 250 peer-reviewed papers in the field of longevity.2

Achievements and Recognition

Fellow of the American Association for the Advancement of Science (AAAS), American Aging Association (AGE), and Gerontological Society of America (GSA)2
Recipient of several prestigious awards, including the Vincent Cristofalo Rising Star in Aging Research Award and the Robert W. Kleemeier Award2 5
Named "Healthcare Innovator of the Year" by Puget Sound Business Journal in 20231

Role at Optispan

As CEO of Optispan, Dr. Kaeberlein is leading the company's efforts to develop scalable technologies for healthspan medicine.1 The company's mission is to provide "Optimal Healthspans for Everyone" by focusing on proactive, preventive healthcare solutions rather than traditional reactive disease care.1 4